While our finding that Obatoclax can inhibit cyclin D1 in MI-BC cells was initially unexpected and has not previously been reported, a subsequent review of the literature revealed that two other studies have shown that Obatoclax can inhibit cyclin D1 in colorectal cancer cells [44,45]. This evidence concerns the gene CCND1 and breast cancer.